Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, United Therapeutics (UTHR) has a market cap of $12.79 billion USD. According to our data, United Therapeutics is ranked No.1317 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $12.79 B |
-18.79%
|
| Dec 31, 2024 | $15.75 B |
60.46%
|
| Dec 29, 2023 | $9.82 B |
-20.93%
|
| Dec 30, 2022 | $12.42 B |
28.70%
|
| Dec 31, 2021 | $9.65 B |
42.35%
|
| Dec 31, 2020 | $6.78 B |
72.33%
|
| Dec 31, 2019 | $3.93 B |
-19.12%
|
| Dec 31, 2018 | $4.86 B |
-26.39%
|
| Dec 29, 2017 | $6.61 B |
3.15%
|
| Dec 30, 2016 | $6.40 B |
-8.42%
|
| Dec 31, 2015 | $6.99 B |
20.94%
|
| Dec 31, 2014 | $5.78 B |
14.51%
|
| Dec 31, 2013 | $5.05 B |
111.68%
|
| Dec 31, 2012 | $2.38 B |
13.06%
|
| Dec 30, 2011 | $2.11 B |
-25.26%
|
| Dec 31, 2010 | $2.82 B |
20.08%
|
| Dec 31, 2009 | $2.35 B |
68.35%
|
| Dec 31, 2008 | $1.40 B |
-35.94%
|
| Dec 31, 2007 | $2.18 B |
79.60%
|
| Dec 29, 2006 | $1.21 B |
-21.34%
|
| Dec 30, 2005 | $1.54 B |
53.09%
|
| Dec 31, 2004 | $1.01 B |
96.73%
|
| Dec 31, 2003 | $0.51 B |
37.43%
|
| Dec 31, 2002 | $0.37 B |
60.42%
|
| Dec 31, 2001 | $0.23 B |
-29.42%
|
| Dec 29, 2000 | $0.33 B |
-67.93%
|
| Dec 31, 1999 | $1.03 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 Incyte
INCY
|
$11.31 B |
0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
USA
|
 bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
Switzerland
|
| Market Cap | = | UTHR Stock Price | * | UTHR Shares Outstanding |
| = | $284.82 | * | 44.91 M | |
| = | $12.79 B |